Keryx Biopharmaceuticals Inc (KERX)

Add to Watchlists
Create an Alert
3.36 +0.00  +0.00% NASDAQ Dec 17, 20:00 Delayed 2m USD

Keryx Biopharmaceuticals Inc Total Liabilities (Quarterly):

206.00M for Sept. 30, 2018
View 4,000+ financial data types
Browse...
View Full Chart

Keryx Biopharmaceuticals Inc Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

Keryx Biopharmaceuticals Inc Historical Total Liabilities (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2018 206.00M
June 30, 2018 186.84M
March 31, 2018 171.73M
Dec. 31, 2017 172.97M
Sept. 30, 2017 164.86M
June 30, 2017 158.54M
March 31, 2017 150.22M
Dec. 31, 2016 149.72M
Sept. 30, 2016 146.64M
June 30, 2016 151.85M
March 31, 2016 180.14M
Dec. 31, 2015 171.75M
Sept. 30, 2015 33.58M
June 30, 2015 30.02M
March 31, 2015 37.18M
Dec. 31, 2014 30.14M
Sept. 30, 2014 28.20M
June 30, 2014 18.59M
March 31, 2014 16.41M
Dec. 31, 2013 15.37M
Sept. 30, 2013 16.50M
June 30, 2013 11.83M
March 31, 2013 8.68M
Dec. 31, 2012 8.075M
Sept. 30, 2012 7.687M
   
June 30, 2012 9.294M
March 31, 2012 12.40M
Dec. 31, 2011 12.44M
Sept. 30, 2011 12.56M
June 30, 2011 9.399M
March 31, 2011 9.247M
Dec. 31, 2010 8.866M
Sept. 30, 2010 10.38M
June 30, 2010 9.028M
March 31, 2010 8.17M
Dec. 31, 2009 8.721M
Sept. 30, 2009 10.50M
June 30, 2009 9.11M
March 31, 2009 26.91M
Dec. 31, 2008 28.12M
Sept. 30, 2008 30.38M
June 30, 2008 34.18M
March 31, 2008 41.93M
Dec. 31, 2007 36.64M
Sept. 30, 2007 27.90M
June 30, 2007 15.34M
March 31, 2007 18.24M
Dec. 31, 2006 16.49M
Sept. 30, 2006 13.40M
June 30, 2006 10.98M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Advertisement

KERX Total Liabilities (Quarterly) Benchmarks

Benchmarks
Akebia Therapeutics Inc 261.28M
Processa Pharmaceuticals Inc 0.1153M
Karyopharm Therapeutics Inc 48.91M

KERX Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 15.37M Dec 2013
Maximum 206.00M Sep 2018
Average 111.04M

KERX Total Liabilities (Quarterly) Excel Add-In Codes

  • Metric Code: liabilities
  • Latest data point: =YCP("KERX", "liabilities")
  • Last 5 data points: =YCS("KERX", "liabilities", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.